[Skip to Navigation]
Views 448
Citations 0
Comment & Response
March 12, 2020

Radical Radiotherapy Should Remain the Standard of Care for Carcinoma Oropharynx

Author Affiliations
  • 1Department of Radiation Oncology, Dr Ram Manohar Lohia Institute of Medical Sciences (Dr RMLIMS), Lucknow, India
JAMA Otolaryngol Head Neck Surg. 2020;146(5):504-505. doi:10.1001/jamaoto.2020.0089

To the Editor We commend Hutcheson et al1 on their interesting study; however, a few points need to be addressed.

This study, being a retrospective toxic effects analysis, has various problems, chief among which is the lack of a priori decided end points. Although a 6-month period seems to be clinically meaningful, the lack of an a priori decided effect size remains an issue. Furthermore, the general dictum in oncologic care is to expose the patient to only 1 form of definitive treatment modality if it is deemed adequate.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words